MORRISVILLE, North Carolina, March 21, 2017 /PRNewswire/ --
Worldwide Clinical Trials (http://www.worldwide.com)has announced the latest additions to its free webinar series, with two webinars taking place in March and April to commemorate Multiple Sclerosis (MS) and Parkinson's awareness months. The first of two informative sessions will address the emerging
On Thursday, March 23, at 11 a.m. ET, Worldwide will host a webinar, titled "The Biosimilar Market: An Evolving Landscape in MS Research," to commemorate MS Awareness Month. Participants will hear from Tomislav Babic, M.D., Ph.D., Vice President of the Neuroscience Franchise at Worldwide, and Manolo E. Beelke, M.D., Ph.D., Medical and Scientific Affairs at Worldwide. They will address the emerging biosimilar market and the problem-solving challenges it presents for designing clinical development programs for Relapsing-Remitting Multiple Sclerosis (RRMS).
The next webinar in the series will celebrate Parkinson's Awareness Month on Thursday, April 20, at 11 a.m. ET. The webinar, titled "Research Challenges in Early Parkinson's Disease: Diagnosis, Trial Design & Rater Training," will also be hosted by Dr. Babic, who will be joined by his Worldwide colleagues: Rolana Avrumson, Director of Clinical Projects, Medical and Scientific Affairs; Travis Caudill, Senior Director, Feasibility & Recruitment Optimization; and Tamara Ast, Ph.D., Vice President, Project Delivery, Neuroscience. They will discuss the prevalence and understanding of early and prodromal PD, as well as new treatment concepts and key success factors that can impact the design of clinical trials.
Both webinars are free to attendees. To learn more, visit http://www.worldwide.com/webinars or register directly at:
Connect with Worldwide Clinical Trials:
About Worldwide Clinical Trials:
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit Worldwide.com.
SOURCE Worldwide Clinical Trials
Subscribe to our Free Newsletters!
Snake antivenom is a medicine used for the treatment of patients suffering from snake envenomation.